D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 52 000 KRW 3.59% Market Closed
Market Cap: ₩486.2B

Operating Margin

0.5%
Current
Improving
by 0.7%
vs 3-y average of -0.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.5%
=
Operating Income
₩3.8B
/
Revenue
₩770.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.5%
=
Operating Income
₩3.8B
/
Revenue
₩770.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Dong-A ST Co Ltd
KRX:170900
476.2B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
38th
Based on 2 615 companies
38th percentile
0.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Dong-A ST Co Ltd
Glance View

Market Cap
486.2B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
70 000.57 KRW
Undervaluation 26%
Intrinsic Value
Price
D
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
0.5%
=
Operating Income
₩3.8B
/
Revenue
₩770.6B
What is Dong-A ST Co Ltd's current Operating Margin?

The current Operating Margin for Dong-A ST Co Ltd is 0.5%, which is above its 3-year median of -0.2%.

How has Operating Margin changed over time?

Over the last 3 years, Dong-A ST Co Ltd’s Operating Margin has decreased from 3.5% to 0.5%. During this period, it reached a low of -3.6% on Dec 31, 2024 and a high of 3.5% on Aug 30, 2022.

Back to Top